Galectin Therapeutics Inc. (GALT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 4.08M | 3.37M | 4.2M | 4.63M | 7.9M | 12.43M | 9.07M | 11.29M | 9.65M | 9.56M | 9.17M | 9M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.85M | 1.43M | 1.59M | 1.36M | 1.41M | 1.32M | 1.47M | 1.48M | 1.59M | 1.33M | 1.43M | 1.63M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.23M | 1.93M | 2.61M | 3.26M | 6.49M | 11.11M | 7.59M | 9.81M | 8.05M | 8.23M | 7.73M | 7.37M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.08M | -3.37M | -4.2M | -4.63M | -7.9M | -12.43M | -9.07M | -11.29M | -9.65M | -9.56M | -9.17M | -9M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 48.37% | 72.92% | 53.7% | 59.04% | 18.15% | -29.99% | 1.09% | -25.41% | 6.71% | 10.08% | -12.85% | 6.82% |
| EBITDA | -4.07M | -3.32M | -6.36M | -4.62M | -7.89M | -12.42M | -9.06M | -11.28M | -9.64M | -9.55M | -9.16M | -8.46M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 48.46% | 73.23% | 29.73% | 59.02% | 18.18% | -30% | 1.1% | -33.29% | 6.51% | 10.1% | -12.85% | 12.34% |
| D&A (Non-Cash Add-back) | 12K | 41K | 0 | 2K | 10K | 10K | 9K | 9K | 9K | 9K | 8K | 0 |
| EBIT | -4.08M | -3.56M | -6.36M | -5.7M | -7.89M | -10.24M | -9.73M | -11.1M | -10.44M | -9.15M | -9.59M | -8.46M |
| Net Interest Income | -1.95M | -1.91M | -1.78M | -1.8M | -1.71M | -1.64M | -1.4M | -1.19M | -972K | -773K | -773K | -600K |
| Interest Income | 36K | 26K | 39K | 26K | 35K | 84K | 93K | 80K | 80K | 74K | 62K | 50K |
| Interest Expense | 1.99M | 1.94M | 1.82M | 1.83M | 1.74M | 1.73M | 1.49M | 1.27M | 1.05M | 847K | 835K | 650K |
| Other Income/Expense | -969K | -2.13M | -3.99M | -2.9M | -1.73M | 461K | -2.15M | -1.08M | -1.84M | -436K | -1.26M | -111K |
| Pretax Income | -5.05M | -5.5M | -8.18M | -7.52M | -9.63M | -11.97M | -11.22M | -12.37M | -11.49M | -10M | -10.43M | -9.11M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -5.05M | -5.5M | -8.18M | -7.52M | -9.63M | -11.97M | -11.22M | -12.37M | -11.49M | -10M | -10.43M | -9.11M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 47.61% | 54.04% | 27.06% | 39.2% | 16.17% | -19.71% | -7.59% | -35.74% | 0.33% | 5.99% | -21.3% | 5.19% |
| Net Income (Continuing) | -5.05M | -5.5M | -8.18M | -7.52M | -9.63M | -11.97M | -11.22M | -12.37M | -11.49M | -10M | -10.43M | -9.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 | -0.19 | -0.18 | -0.20 | -0.19 | -0.16 | -0.24 | -0.15 |
| EPS Growth % | 48.67% | 57.89% | 27.78% | 40% | 21.05% | -18.75% | 25% | -33.33% | 0% | 68.63% | -71.43% | 6.25% |
| EPS (Basic) | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 | -0.19 | -0.18 | -0.20 | -0.19 | -0.16 | -0.24 | -0.15 |
| Diluted Shares Outstanding | 65.78M | 63.9M | 64.2M | 63.45M | 63.2M | 62.74M | 62.28M | 62.23M | 61.98M | 60.16M | 59.7M | 59.58M |
| Basic Shares Outstanding | 65.78M | 63.9M | 64.2M | 63.45M | 63.2M | 62.74M | 62.28M | 62.23M | 61.98M | 60.16M | 59.7M | 59.58M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |